Noble Pharma, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Noble Pharma, LLC - overview
Established
2018
Location
Menomonie, WI, US
Primary Industry
Pharmaceuticals
About
Based in Wisconsin, US, and founded in 2018, Noble Pharma, LLC operates as a manufacturer of palatable products for animal health pharmaceuticals including chews, creams, ointments, suspensions, tablets, powders, and pastes. In January 2022, DW Healthcare Partners invested in Noble Pharma, LLC. As of March 2022, the company is led by its CEO Raj Lall. Noble Pharma, LLC develops, formulate, and manufacture oral and topical drug products.
Its Dosage forms include soft chews, tablets, boluses, powders, oral/topical liquids, suspensions, pastes, gels, creams, and ointments. The facility includes a robust Quality Management System, Quality Control laboratories including analytical and microbiology, research and laboratories, and stability testing capabilities. Noble Pharma, LLC plans to use the funds from January 2022, to enhance its CMO customer relationships, expand capabilities and operations, and accelerate new product commercialization.
Current Investors
DW Healthcare Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pet Products, Pharmaceutical Research & Development
Website
www.noblepharmallc.com
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Noble Pharma, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Noble Pharma, LLC | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.